The straightforward enantioselective construction of the hydroquinoline ring system from 1,5-polycarbonyl derivatives, using (R)-phenyglycinol as a chiral latent form of ammonia, is reported.
The application of this biomimetic double cyclocondensation methodology to the enantioselective synthesis of the decahydroquinoline alkaloid cis-195A, which incorporates a C-5 methyl substituent, required starting from a diketoester 2b, bearing a methyl ketone moiety. This 1,5-polycarbonyl derivative was prepared in 65% yield by Pd-catalyzed coupling of the organozinc derivative 1 with 5-oxohexanoyl chloride. In this series, the initial aldol cyclocondensation to 4b took place in 82% yield, whereas the phenylglycinol-promoted cyclocondensation stereoselectively provided tricyclic lactam 5b in 70% yield. The configuration of the stereogenic ring fusion carbon atoms generated in this step was unambiguously established by X-ray crystallographic analysis.
The conversion of lactam 5b to the target alkaloid required the stereoselective hydrogenation of the carbon-carbon double bond, the introduction of the propyl substituent at C-2, and the reductive removal of the chiral inductor. The catalytic hydrogenation of 5b using PtO2 as the catalyst took place in nearly quantitative yield and complete selectivity from the most accessible face to give lactam 6, whose absolute configuration was unambiguously established by X-ray crystallographic analysis (Scheme 5).
SCHEME 5. Enantioselective Synthesis of Pumiliotoxin C
epimerization at the perhydroquinoline C-4a position, debenzylation and, finally, introduction of the protective group.
The hydrogenation of the exocyclic C─C double bond of 13 is the first event of this multistep sequence, as evidenced by the rapid disappearance (3h) of the NMR singlet at δ 4.38 attributable to the vinyl proton α to the carbonyl group when operating under neutral conditions (PtO2, MeOH). The resulting intermediate B is then converted to the perhydro derivative C, as indicated by the successive disappearance of the NMR signals due to the exocyclic and endocyclic (broad singlet at δ 5.42) double bonds, when the hydrogenation was effected using Pd/C as the catalyst in methanol. Under acidic conditions (PtO2, MeOH, excess AcOH), this intermediate was formed in 30 min, and after prolonged reaction times it evolved into the secondary amine precursor of ent-2-epi-10.
A similar stereochemical result was obtained starting from diester 16. The stereochemical outcome of the hydrogenation of 13 was quite surprising because two configurationally related substrates (5b and 13) lead to two diastereoisomers (10 and ent-2-epi-10, respectively) differing in the absolute configuration of three stereocenters. This result can be rationalized by considering that the hydrogenation of the endocyclic C─C double bond of the conformationally rigid tricyclic derivatives 5b and B occurs with differing facial selectivity and that the absolute configuration of the stereocenter generated in this step (C-5) determines the stereochemistry of the configurationally labile C-4a stereocenter under the acidic conditions required for the reductive cleavage of the oxazolidine ring.
A reasonable explanation for the contrasting stereoselectivity in the above hydrogenation step can be obtained by analyzing the most stable conformations of 5b and B obtained by molecular orbital calculations (Scheme 8). Thus, although the presence of an axial C─O bond in 5b directs the uptake of hydrogen to the opposite α face to give 6, the axial acetate chain on the concave face of the hydroquinoline moiety in B reverses this situation and the hydrogenation occurs on the less hindered β-face to provide the intermediate C.
SCHEME 8. Stereochemical Outcome of the C─C Double Bond Hydrogenation
On the other hand, the C-4a configuration in ent-2-epi-10, opposite to that in 13, can be accounted for by considering that the acid-promoted opening of the oxazolidine ring in C leads to an intermediate iminium salt Xa (Scheme 9), which is in equilibrium via the corresponding enamine with the most stable epimer Ya (equatorial methyl group) in a process involving the inversion of the configuration at the C-4a stereocenter. A subsequent stereoselective hydrogenation of the iminium function and debenzylation, followed by protection with Boc2O, leads to cis-decahydroquinoline ent -2-epi-10. 18 In contrast, the C-4a epimerization does not occur in the pumiliotoxin C series, in which the iminium intermediate Xb (equatorial methyl group), generated after an initial stereoselective reduction of the exocyclic double bond of 8, is directly converted to the cis-decahydroquinoline 10. SCHEME 9. The Configuration of the Ring Junction 
Conclusion
In summary, starting from an easily accessible (R)-phenylglycinol-derived tricyclic lactam 5b, depending on the order of the synthetic transformations (paths A or B), it is possible to enantioselectively access 5-substituted cis-decahydroquinoline-2-acetate derivatives that differ in the configuration of the 4a, 5, and 8a stereocenters (Scheme 10). The results reported in this paper not only provide experimental support for the presumed biosynthetic pathway to amphibian decahydroquinoline alkaloids but also open general enantioselective routes to both the cis and the 2-epi-cis-series of these alkaloids, which differ in the nature of the substituents at the 2 and 5 positions and in the relative C-2 configuration (see Figure 1) . Starting from an appropriate (R)-phenyglycinol-derived tricyclic lactam, the above path A provides access to the normal cis-series, whereas when using an (S)-phenylglycinol-derived lactam, the above path B would lead to decahydroquinoline alkaloids of the 2-epi-cis series (Scheme 11). Ethyl 5,9-dioxodecanoate (2b). A mixture of oxalyl chloride (38 mL, 0.44 mol) and 5-oxohexanoic acid (12 mL, 0.1 mol) in anhydrous Et2O (100 mL) was stirred at rt for 6 h. The solution was concentrated, and the resulting residue was dried to give the acid chloride, which was used in the next step without further purification. A solution of 4-ethoxy-4-oxobutylzinc bromide (1; 200 mL of a 0.5 M solution in THF, 0.1 mol) and Pd[P(C6H5)3]4 (5.8 g, 5 mmol) in THF (400 mL) was stirred at rt for 30 min. Then, the above acid chloride was added, and the resulting mixture was stirred at rt for 16 h. The mixture was poured into saturated aqueous NH4Cl and extracted with Et2O. The combined organic extracts were washed with saturated aqueous NaCl, dried, and concentrated to give an oil. Flash chromatography (from 9:1 to 8:2 hexane-EtOAc) afforded diketoester 2b ( 
Ethyl 2-(2-ethoxycarbonylethyl)-3-oxocyclohexenebutyrate (4a).
A solution of LiOH·H2O (8 g, 0.2 mol) in water (125 mL) was added to a solution of 2a (6 g, 18.3 mmol) in THF (300 mL) and EtOH (350 mL), and the mixture was stirred at rt for 3 h. The mixture was concentrated, and the residue was taken up in 2N aqueous HCl and extracted with EtOAc. The combined organic extracts were dried and concentrated to give 2-(2-carboxyethyl)-3-oxocyclohexenebutyric acid, which was used in the next step without further purification. Me3SiCl (10 mL, 80 mmol) was added to a solution of the acid in EtOH (105 mL), and the mixture was stirred at rt for 16 h. The mixture was concentrated, and the residue was taken up in EtOAc and washed with saturated aqueous NaHCO3. The combined organic extracts were dried and concentrated to give ketodiester 4a (5.1 g, 90%) as an oil 
Methyl 2-methyl-6-oxocyclohexenepropionate (4b).
Operating as in the above preparation of 4a, from diketoester 2b (7.5 g, 33 mmol), LiOH·H2O (15 g, 0.35 mol), and EtOH (375 mL) for 5h, and then Me3SiCl (13 mL, 0.1 mol) and MeOH (80 mL), ketoester 4b (5.5 g, 85%) was obtained as CHCl3 (18 mL) was stirred at rt for 17 h in the dark. The mixture was concentrated, and the residue was taken up with CHCl3 (18 mL). Trimethyl phosphite (2.2 mL, 18.6 mmol) and Et3N (6 mL) were added, and the resulting solution was heated at reflux for 24 h. The mixture was allowed to cool to rt and concentrated. The residue was chromatographed (9:1 hexane-EtOAc) to afford 8 ( (180 mg, 0.61 mmol) in anhydrous CH2Cl2 (5 mL), and the mixture was stirred at rt for 2.5 h. Then, Et2O (9 mL), 1M aqueous Na2S2O4 (2 mL), and saturated aqueous NaHCO3 (2 mL) were added, and the resulting mixture was stirred for 45 min. The aqueous layer was extracted with Et2O, and the combined organic extracts were washed with brine, dried, and concentrated to give the corresponding aldehyde as an oil, which was used without further purification in the next step. BuLi (0.9 mL of a 1.6 M solution in hexane, 1.4 mmol) was added to a solution of methyltriphenylphosphonium bromide (535 mg, 1.5 mmol) in THF (5 mL) at 0 ºC, and the mixture was stirred for 1.5 h. Then, a solution of the above aldehyde in THF (2 mL) was added, and the resulting mixture was stirred at rt for 16 h. Saturated aqueous NH4Cl was added, and the resulting mixture was extracted with CH2Cl2. The combined organic extracts were washed with saturated aqueous NaCl, dried, and concentrated. Operating as in the preparation of 7, from lactam 5b (2.4 g, 8.5 Schultz, A. G.; McCloskey, P. J.; Court, J. J. J. Am. Chem. Soc. 1987, 109, 6493-6502. (j) (13) For a preliminary account on the synthesis of pumiliotoxin C, see: Amat, M.; Griera, R.;
(3R,7aS,8R,11aS)-8-Methyl-5-oxo-3-phenyldecahydrooxazolo[2,3-j]quinoline (6).
Fabregat, R.; Molins, E.; Bosch, J. Angew. Chem. Int. Ed. 2008, 47, 3348-3351. (14) In some runs, the seven-membered lactone 14 was isolated as a by-product, which was subsequently converted to ent-2-epi-10 by catalytic hydrogenation (Pd-C, MeOH) in the presence of Boc2O. 
